Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a

@article{Lip2010AntithromboticMO,
  title={Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a},
  author={Gregory Y H Lip and Kurt Walter Huber and Felicita Andreotti and Harald Arnesen and Juhani K Airaksinen and Thomas Cuisset and Paulus Kirchhof and Francisco Miguel Aguila Marin},
  journal={European heart journal},
  year={2010},
  volume={31 11},
  pages={
          1311-8
        }
}
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full consensus document comprehensively reviews the published evidence and presents a consensus statement on… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 102 CITATIONS, ESTIMATED 38% COVERAGE

Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review.

  • Journal of the American College of Cardiology
  • 2014
VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Triple antithrombotic therapy with prasugrel in the stented patient: concern for more bleeding.

  • Journal of the American College of Cardiology
  • 2013
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Safety of radial coronary angiography with uninterrupted direct-acting oral anticoagulant treatment.

  • Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
  • 2018
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 6 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 86 REFERENCES

Atrial fibrillation and stroke prevention

  • The Lancet Neurology
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis

J Ruiz-Nodar, F Marı́n, +7 authors G. Lip
  • J Am Coll Cardiol
  • 2008
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers